Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study
scientific article
Author/s
author: Nicola Polverelli, Elisabetta Abruzzese, Alessandro Isidori, Francesca Palandri, Giuseppe Alberto Palumbo, Mario Tiribelli, Massimo Breccia, Roberto Latagliata, Bruno Martino, Florian H Heidel, Massimiliano Bonifacio, Micaela Bergamaschi, Alessia Tieghi, Monica Crugnola, Francesco Cavazzini, Gianni Binotto, Nicola Sgherza, Luigi Scaffidi, Antonio Cuneo, Michele Cavo, Giulia Benevolo, Francesco Buccisano, Marco Spinsanti
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.